A study by a team of scientists in France has found that the introduction of a third drug in chemotherapy for malignant pleural mesothelioma could potentially make a significant impact on mesothelioma survival.
The major new study saw the overall survival improved in a group of mesothelioma patients. The standard of care for mesothelioma chemotherapy includes a combination of Alitma and cisplatin for over a decade. The new treatment saw a significant impact from the introduction of a third drug, Avastin (bevacizumab), as part of a six-year Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS).
The study involved 448 mesothelioma patients, with drugs administered in 21-day cycles. Avastin is an angiogenesis inhibitor, which slows the growth of new blood vessels that feed growing mesothelioma tumours. The study concluded that Avastin “should be considered as a suitable treatment for the disease.”
The most recent statistics, as compiled for the British Lung Foundation’s Respiratory Health of the Nation project, reveal that in 2012, 5,420 people were diagnosed with mesothelioma, with almost four times as many men as women. In 2012, 2,431 people died from mesothelioma. The news of the new treatment’s effect on mesothelioma, is a positive step towards tackling this terrible disease and, though not a cure, sufferers and their families will be given more time.
A major cause of mesothelioma is exposure to asbestos. One of the tragedies of being diagnosed with mesothelioma is that the diagnosis is so long after the person was exposed to asbestos that the victim may not remember.
If you have worked with or been exposed to asbestos and are suffering from the symptoms of a respiratory illness, we advise that you make an appointment with your GP for peace of mind.
Register Your Exposure to Asbestos Today
In the unfortunate event that you are exposed to asbestos it is essential that you register this exposure as soon as possible.
For further information on mesothelioma, see our previous blog Mesothelioma: Ensure You Have That Cold Checked Thoroughly.
Patrick Walsh is a personal injury lawyer specialising in industrial disease claims at Slater and Gordon in Manchester.
The Slater and Gordon chest and asbestos disease team have worked with many sufferers and families affected by mesothelioma. For a free consultation call freephone 0800 884 0275 or contact us online and we’ll be happy to help you.